🇺🇸 Xibrom in United States

87 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Chronic Kidney Disease — 14 reports (16.09%)
  2. Renal Failure — 11 reports (12.64%)
  3. Visual Acuity Reduced — 10 reports (11.49%)
  4. Acute Kidney Injury — 9 reports (10.34%)
  5. Eye Pain — 9 reports (10.34%)
  6. Death — 8 reports (9.2%)
  7. End Stage Renal Disease — 7 reports (8.05%)
  8. Nausea — 7 reports (8.05%)
  9. Dizziness — 6 reports (6.9%)
  10. Eye Irritation — 6 reports (6.9%)

Source database →

Other Pain approved in United States

Frequently asked questions

Is Xibrom approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Xibrom in United States?

Bp Consulting, Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.